Feasibility study evaluating neurological impairment in critically ill dialysis patients

https://storage.unitedwebnetwork.com/files/1099/1f45e36312eecde20bc1aceb277886e9.pdf
Feasibility study evaluating neurological impairment in critically ill dialysis patients
Natasha
Jawa
Samuel Silver samuel.silver@queensu.ca Queen's University
Rachel Holden rachel.holden@kingstonhsc.ca Queen's University
Steven Scott steve.scott@queensu.ca Queen's University
Andrew Day daya@queensu.ca Queen's University
Patrick Norman patrick.norman@kingstonhsc.ca Kingston General Health Research Institute
Benjamin Kwan benjamin.kwan@kingstonhsc.ca Queen's University
David Maslove david.maslove@queensu.ca Queen's University
John Muscedere john.muscedere@kingstonhsc.ca Queen's University
J. Gordon Boyd gordon.boyd@kingstonhsc.ca Queen's University
 
 
 
 
 
 

Acute kidney injury (AKI) resulting in kidney replacement therapy (KRT) is rising among critically ill adults. Long-term KRT and critical illness are independently linked to acute (i.e., delirium) and prolonged cognitive impairment and structural brain pathology. Poor regional cerebral oxygenation (rSO2) may be a contributing factor. This study sought to determine whether undertaking a longitudinal study of critically ill patients initiated on KRT was feasible. We aimed to identify barriers to enrolment and data collection, to design mitigation strategies for a future study exploring the neurological issues facing this cohort.

We enrolled adults greater than or equal to 18 years with severe AKI stage 2/3 within 12-hours of initiating continuous KRT (CKRT) or intermittent hemodialysis in the Kingston Health Sciences Centre Intensive Care Unit (ICU). rSO2 was monitored during the first 72h of CKRT or throughout each intermittent hemodialysis session. We measured acute neurological impairment by daily delirium screening (Confusion Assessment Method), and long-term neurocognitive outcomes using the Kinarm robot, Repeatable Battery for the Assessment of Neuropsychological Status, and brain MRI. Feasibility was assessed through 1) enrolment (defined as greater than or equal to 1 per month), 2) data capture rates (greater than or equal to 80%), and 3) follow-up rates at 3- and 12-months (greater than or equal to 70%).

Of 484 ICU patients, 26 met screening criteria. Two declined, and 13 met at least one exclusion criteria. Eleven were enrolled. Eight died in ICU, one died two months after discharge, and one declined follow-up. Data capture rates were high: rSO2/vitals (91.3%), delirium screening/demographics (100%). Longitudinal testing was completed in 50% (1 of 2) of survivors. Enrolment was low due to a variety of factors, limiting our ability to evaluate long-term outcomes.

It is feasible to collect cerebral oxygenation and delirium data in critically ill patients undergoing kidney replacement therapy. Long-term follow-up may be challenging due to high mortality. 

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos